CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash Flows from Operating Activities:
Net income	$ 12,463	$ 9,946
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	3,546	3,357
Amortization on right-of-use assets	3,284	3,306
Provision for bad debts	1,674	4,441
Deferred income tax – net	3,003	1,931
Gain on sale of equipment – related party	(577)	0
(Increase) decrease in operating assets, net:
Accounts, medical and management fee receivable(s)	(8,835)	(5,604)
Notes receivable	55	11
Inventories	(365)	(301)
Prepaid expenses and other current assets	243	(73)
Other assets	(28)	0
Increase (decrease) in operating liabilities, net:
Accounts payable	97	168
Other current liabilities	(1,095)	(4,409)
Operating lease liabilities	(3,756)	(2,865)
Financing lease liabilities	(163)	(175)
Customer deposits	(49)	465
Other liabilities	(1)	(49)
Net cash provided by operating activities	9,496	10,149
Cash Flows from Investing Activities:
Purchases of property and equipment	(375)	(3,553)
Purchase of short term investment	(102)	0
Cost of patents	(24)	(87)
Net cash used in investing activities	(501)	(3,640)
Cash Flows from Financing Activities:
Repayment of borrowings and capital lease obligations	(32)	(26)
Purchase of treasury stock	(1,885)	(1,249)
Distributions to non controlling interests	(4,376)	(4,317)
Net cash used in financing activities	(6,293)	(5,592)
Net Increase in Cash and Cash Equivalents	2,702	917
Cash and Cash Equivalents - Beginning of Period	51,280	48,723
Cash and Cash Equivalents - End of Period	$ 53,982	$ 49,640